Additional studies have also identified epigenetic reprogramming of the transcriptional repressive mark, H3K27me3, in cell populations resistant to chemotherapy in TNBC and to tamoxifen in ER + breast cancer patient-derived xenografts (PDXs)83. This evidence concerns the gene ESR1 and breast cancer.